These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 10815698

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 3. Serum dehydroepiandrosterone and dehydroepiandrosterone sulfate and risk of melanoma or squamous cell carcinoma of the skin.
    Alberg AJ, Gordon GB, Genkinger JM, Hoffman SC, Selvin E, Comstock GW, Helzlsouer KJ.
    Anticancer Res; 2001 Mar; 21(6A):4051-4. PubMed ID: 11911290
    [Abstract] [Full Text] [Related]

  • 4. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 5. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2006 May 18; 15(5):967-71. PubMed ID: 16702378
    [Abstract] [Full Text] [Related]

  • 6. The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.
    Comstock GW, Gordon GB, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 1993 May 18; 2(3):219-21. PubMed ID: 8318873
    [Abstract] [Full Text] [Related]

  • 7. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease.
    Khaw KT.
    J Endocrinol; 1996 Sep 18; 150 Suppl():S149-53. PubMed ID: 8943798
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate and the risk of developing gastric cancer.
    Gordon GB, Helzlsouer KJ, Alberg AJ, Comstock GW.
    Cancer Epidemiol Biomarkers Prev; 1993 Sep 18; 2(1):33-5. PubMed ID: 8420609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alterations in DHEA metabolism in schizophrenia: two-month case-control study.
    Ritsner M, Gibel A, Ram E, Maayan R, Weizman A.
    Eur Neuropsychopharmacol; 2006 Feb 18; 16(2):137-46. PubMed ID: 16139994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer.
    Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW.
    Cancer Res; 1990 Jul 01; 50(13):3859-62. PubMed ID: 2141293
    [Abstract] [Full Text] [Related]

  • 17. C-reactive protein concentrations and subsequent ovarian cancer risk.
    McSorley MA, Alberg AJ, Allen DS, Allen NE, Brinton LA, Dorgan JF, Pollak M, Tao Y, Helzlsouer KJ.
    Obstet Gynecol; 2007 Apr 01; 109(4):933-41. PubMed ID: 17400857
    [Abstract] [Full Text] [Related]

  • 18. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M, Yüceyar H, Ayhan S, Türkel N, Tuzcuoglu I, Can M.
    Hepatogastroenterology; 2003 Apr 01; 50(51):771-4. PubMed ID: 12828082
    [Abstract] [Full Text] [Related]

  • 19. Serum dehydroepiandrosterone sulfate levels predict longevity in men: 27-year follow-up study in a community-based cohort (Tanushimaru study).
    Enomoto M, Adachi H, Fukami A, Furuki K, Satoh A, Otsuka M, Kumagae S, Nanjo Y, Shigetoh Y, Imaizumi T.
    J Am Geriatr Soc; 2008 Jun 01; 56(6):994-8. PubMed ID: 18422949
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.
    Barrett-Connor E, Khaw KT, Yen SS.
    N Engl J Med; 1986 Dec 11; 315(24):1519-24. PubMed ID: 2946952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.